RIDA®Xtract 96* (Coming Soon)
Efficient Sample Purification for up to 96 Samples
The RIDA®Xtract 96 is a semi-automated nucleic acid extraction platform engineered for laboratories performing high-throughput molecular diagnostics. Combining advanced liquid handling robotics with proven magnetic bead extraction technology, the system delivers high-quality DNA and RNA purification from a wide range of specimen types with exceptional consistency. Designed to process up to 96 samples per run with minimal hands-on time, the RIDA®Xtract 96 enables laboratories to increase capacity, standardise workflows and confidently meet growing testing demands.
Features & Benefits
- Use with RIDA®Xtract 96 RNA/DNA Extraction Kit (Currently Under Rebranding)
- Universal extraction – process different sample types at the same time
- Minimal 10 minutes of hands-on time
- Automatic barcode scanning for end-to-end traceability
- Intuitive software allows for greater control of sample processing
Aligned Technology for Unmatched Capability
The RIDA®Xtract 96 integrates advanced robotic liquid handling with magnetic bead-based nucleic acid purification to deliver consistent extraction performance across high-volume testing workflows. Every stage of the process has been optimised to maximise DNA and RNA yield while reducing manual intervention, helping laboratories achieve reliable downstream PCR performance with greater efficiency. The platform’s flexible design supports a broad range of specimen types, allowing laboratories to standardise extraction protocols across multiple diagnostic applications without compromising quality or throughput.
Persistent Precision
At the heart of the RIDA®Xtract 96 is proven Compressed O-Ring Expansion pipetting technology, engineered to deliver highly accurate and reproducible liquid handling. By ensuring secure tip attachment and minimising aerosol generation, the system reduces the risk of cross-contamination while maintaining exceptional dispensing precision throughout every extraction run. This consistent performance supports reliable nucleic acid purification, helping laboratories maintain the quality standards required for demanding molecular diagnostic workflows.
Efficient Parallel Processing
The RIDA®Xtract 96 has been designed to maximise laboratory productivity through intelligent workflow automation. Its dual-position turntable enables one plate to undergo magnetic bead separation while a second plate is simultaneously prepared for the next stage of processing, reducing idle time between workflow steps. This parallel processing capability allows laboratories to increase daily sample throughput, maintain continuous operation and achieve faster turnaround times, all while minimising manual handling and ensuring consistent extraction performance across every batch.
| Dimensions | 135.9 W x 70.9 D x 88.9 H cm (130 H cm With Door Open) |
| Weight | 136kg (approx.) |
| Total Footprint | 136cm |
| Processing Capacity | 1 – 96 Samples per Run |
| Throughput / 8hr Shift | Up to 384 Samples |
| Total Processing Time | Processing Time 1 hr 15 mins (Includes Automated Sample Aliquoting) |
| Sample Volume | 100 – 300μl |
| Elution Volume | 50 – 200μl |
| Protocols | Preinstalled |
| Power Supply | 110 – 240V, 50/60Hz, 5A |
Reliable Automation for Everyday Molecular Diagnostics
The RIDA®Xtract 96 has been developed to meet the demands of laboratories processing large sample volumes without compromising extraction quality or workflow efficiency. Combining intelligent automation, scalable throughput and dependable nucleic acid purification, the platform provides a reliable foundation for downstream molecular diagnostics. Supported by R-Biopharm Australia’s local expertise, the RIDA®Xtract 96 enables laboratories to expand testing capacity while maintaining the accuracy, consistency and traceability required for routine clinical workflows.
Systems are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European Regulation (EU) 2017/746 . In the USA: For Research Use Only (RUO), not for use In diagnostic procedures.
